Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Dage

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1991
Probucol reduces myocardial dysfunction during reperfusion after short-term ischemia in rabbit heartR C Dage, B A Anderson, S J Mao, et al.
Journal of Cardiovascular Pharmacology|March 1, 1991
MDL 27,032 relaxes vascular smooth muscle and inhibits protein kinase CH C Cheng, P J Robinson, R C Dage, et al.
Molecular Pharmacology|September 1, 1993
Verapamil blocks a rapidly activating delayed rectifier K+ channel cloned from human heartD Rampe, B Wible, D Fedida, et al.
Biochemical Pharmacology|May 1, 1987
Antioxidant properties of 2-imidazolones and 2-imidazolthionesR C Smith, J C Reeves, R C Dage, et al.
Journal of Cardiovascular Pharmacology|July 1, 1995
Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertensionJ F French, B A Anderson, T R Downs, et al.
Journal of Cardiovascular Pharmacology|September 1, 1982
Characterization of the cardiovascular activities of a new cardiotonic agent, MDL 17043 (1,3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazole-2-one)L E Roebel, R C Dage, H C Cheng, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1995
Voltage- and time-dependent block by perhexiline of K+ currents in human atrium and in cells expressing a Kv1.5-type cloned channelD Rampe, Z Wang, B Fermini, et al.
Journal of Cardiovascular Pharmacology|May 1, 1982
Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one)R C Dage, L E Roebel, C P Hsieh, et al.
European Journal of Pharmacology|March 16, 1993
Identification of a specific receptor for interleukin-1 in vascular smooth muscle cells: regulation by interleukin-1 and interleukin-6J F French, K K Schroeder, A L Akeson, et al.
Circulatory Shock|July 1, 1994
Protective effects of a cyclic nitrone antioxidant in animal models of endotoxic shock and chronic bacteremiaJ F French, C E Thomas, T R Downs, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Cardiovascular Pharmacology|January 1, 1991
Probucol reduces myocardial dysfunction during reperfusion after short-term ischemia in rabbit heartR C Dage, B A Anderson, S J Mao, et al.
Journal of Cardiovascular Pharmacology|March 1, 1991
MDL 27,032 relaxes vascular smooth muscle and inhibits protein kinase CH C Cheng, P J Robinson, R C Dage, et al.
Molecular Pharmacology|September 1, 1993
Verapamil blocks a rapidly activating delayed rectifier K+ channel cloned from human heartD Rampe, B Wible, D Fedida, et al.
Biochemical Pharmacology|May 1, 1987
Antioxidant properties of 2-imidazolones and 2-imidazolthionesR C Smith, J C Reeves, R C Dage, et al.
Journal of Cardiovascular Pharmacology|July 1, 1995
Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertensionJ F French, B A Anderson, T R Downs, et al.
Journal of Cardiovascular Pharmacology|September 1, 1982
Characterization of the cardiovascular activities of a new cardiotonic agent, MDL 17043 (1,3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazole-2-one)L E Roebel, R C Dage, H C Cheng, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1995
Voltage- and time-dependent block by perhexiline of K+ currents in human atrium and in cells expressing a Kv1.5-type cloned channelD Rampe, Z Wang, B Fermini, et al.
Journal of Cardiovascular Pharmacology|May 1, 1982
Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one)R C Dage, L E Roebel, C P Hsieh, et al.
European Journal of Pharmacology|March 16, 1993
Identification of a specific receptor for interleukin-1 in vascular smooth muscle cells: regulation by interleukin-1 and interleukin-6J F French, K K Schroeder, A L Akeson, et al.
Circulatory Shock|July 1, 1994
Protective effects of a cyclic nitrone antioxidant in animal models of endotoxic shock and chronic bacteremiaJ F French, C E Thomas, T R Downs, et al.
Pageof 5